Gianluca Furneri
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 15, 2023
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy.Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio
|Aug 17, 2021
Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy.Antonio Maria Fea, Francesco Cattel, Stefano Gandolfi
|May 22, 2021
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.Giorgio Walter Canonica, Francesco Blasi, Nunzio Crimi
|Sep 28, 2020
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?Ciro Costagliola, Mario Sbordone, Stefano Gandolfi
|Jun 30, 2019
Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy.Gianluca Furneri, Laura Santoni, Chiara Ricella
Pageof 1
